[HTML] rupress.org

[HTML][HTML] A novel STING variant triggers endothelial toxicity and SAVI disease

E Valeri, S Breggion, F Barzaghi… - Journal of Experimental …, 2024 - rupress.org
Gain-of-function mutations in STING cause STING-associated vasculopathy with onset in
infancy (SAVI) characterized by early-onset systemic inflammation, skin vasculopathy, and …
被引用次数：2 相关文章
[HTML] nih.gov

[HTML][HTML] A novel STING variant triggers endothelial toxicity and SAVI disease

E Valeri, S Breggion, F Barzaghi… - The Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Gain-of-function mutations in STING cause STING-associated vasculopathy with onset in
infancy (SAVI) characterized by early-onset systemic inflammation, skin vasculopathy, and …

A novel STING variant triggers endothelial toxicity and SAVI disease

E Valeri, S Breggion, F Barzaghi… - The Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Gain-of-function mutations in STING cause STING-associated vasculopathy with onset in
infancy (SAVI) characterized by early-onset systemic inflammation, skin vasculopathy, and …

A novel STING variant triggers endothelial toxicity and SAVI disease.

E Valeri, S Breggion, F Barzaghi… - The Journal of …, 2024 - europepmc.org
Gain-of-function mutations in STING cause STING-associated vasculopathy with onset in
infancy (SAVI) characterized by early-onset systemic inflammation, skin vasculopathy, and …

A novel STING variant triggers endothelial toxicity and SAVI disease

E Valeri, S Breggion, F Barzaghi… - JOURNAL OF …, 2024 - iris.unipv.it
: Gain-of-function mutations in STING cause STING-associated vasculopathy with onset in
infancy (SAVI) characterized by early-onset systemic inflammation, skin vasculopathy, and …